| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Moderna, Inc. (MRNA) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. MRNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 1.46M | $70.74M | - | |
| Other | 55.9K | $2.71M | - | |
| Dir | 27.8K | $1.35M | - | |
| CFO | 4.4K | $211.6K | - | |
| Dir | 1.5K | $74.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 1,418 | $42.79 | $60,674.94 | -6.7% | -27.8% | -39.7% | |
| Nov 11, 2024 | Hoge Stephen74 | President | Sale+OE | 277 | $46.10 | $12,771.00 | - | -25.5% | -38.2% | |
| Oct 7, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 715 | $60.12 | $42,985.80 | -7.0% | -27.5% | -53.4% | |
| Sep 9, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 551 | $73.57 | $40,538.78 | -2.9% | -40.4% | -68.1% | |
| Sep 3, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 114 | $76.99 | $8,776.75 | -0.6% | -39.3% | -67.0% | |
| Sep 3, 2024 | Hoge Stephen74 | President | Sale+OE | 318 | $76.99 | $24,482.50 | - | -39.3% | -67.0% | |
| Aug 29, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 162 | $78.03 | $12,640.21 | -1.8% | -44.1% | -69.0% | |
| Aug 29, 2024 | Klinger Shannon Thyme81 | Chief Legal Officer | Sale+OE | 162 | $78.03 | $12,640.21 | -0.9% | -44.1% | -69.0% | |
| Aug 29, 2024 | Hoge Stephen74 | President | Sale+OE | 300 | $78.03 | $23,407.80 | - | -44.1% | -69.0% | |
| Aug 28, 2024 | Mock James M85 | Chief Financial Officer | Sale+OE | 1,321 | $79.39 | $104,880.66 | -13.3% | -46.3% | -68.8% |